Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097565
Status:
COMPLETED
Last Update Posted:
2017-03-23
First Post:
2004-11-24
Brief Title:
An Observational Study of Treatment Outcomes and Prognosis in Patients With Follicular Non-Hodgkins Lymphoma
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
The National Lymphocare Study An Observational Study of Treatment Outcomes and Prognosis in Patients With Follicular Non-Hodgkins Lymphoma
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective observational longitudinal multicenter study of patients with newly diagnosed follicular Non Hodgkins Lymphoma NHL designed to delineate differences in clinical outcome by comparing the effectiveness and safety of common treatment regimens
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None